South Korea
Youngmin Park joins us for our ‘Five minutes with’ series to discuss learning languages, moonlighting as a drummer, and why late is better than never
Jinwon Chun discusses the need for vigilance, his love for iced coffee, and preparing for INTA
Keejeong Kim, who returned to Yulchon after a four-year gap, said he was intrigued by the opportunity to work on neighbouring areas of law to IP
The firm also plans to build an entertainment practice group and up its IP and antitrust offerings with a focus on foreign clients
Sponsored
Sponsored
-
Sponsored by FirstLaw PCSe Jeong Son of FirstLaw PC explains how the Korean Intellectual Property Office has reacted to the significant increase in patent applications across the fields of digital healthcare and biomarkers -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law considers the use of a re-filing strategy against non-use cancellation
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law summarises the eligible drugs, the re-examination period and strategies available for companies
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains how the recent Supreme Court en banc ruling changes precedents on infringement by the use of later-registered trademarks
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law describes how patent challenges have become even more important under the revised drug pricing framework in South Korea
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks at how the Korean Intellectual Property Office (KIPO) and the Korean courts have judged the registrability and validity of pharmaceutical trademarks according to more specific criteria
